Intranasal Oxytocin for Infants With Prader-Willi Syndrome

NCT03245762 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Prader-Willi Syndrome

Interventions

DRUG: Oxytocin
DRUG: Placebo

Sponsor

University of Florida

Collaborators

[object Object]